Listen to Naval G. Daver, MD, discuss his thoughts on the most promising investigational agents and treatment strategies currently in clinical trials for the treatment of patients with acute myeloid leukemia (AML).
In this episode, Naval G. Daver, MD, discusses promising investigational agents and treatment combinations in clinical trials for patients with newly diagnosed and relapsed/refractory AML, including:
Content is part of an online CME program supported by an educational grant from Daiichi-Sankyo.
Link to full program, including a ClinicalThought commentary: https://bit.ly/2Y2uCG2